Bandeira Pamela T, Souza João Pedro A, Scariot Débora B, Garcia Francielle P, Nakamura Celso V, de Oliveira Alfredo R M, Piovan Leandro
Department of Chemistry, Universidade Federal do Parana, Curitiba 4106902, Brazil.
Health Sciences Center, Universidade Estadual de Maringá, Maringá 4115200, Brazil.
ACS Med Chem Lett. 2019 Apr 9;10(5):806-810. doi: 10.1021/acsmedchemlett.9b00060. eCollection 2019 May 9.
Leishmaniasis is a neglected tropical disease and a public health concern in at least 98 countries, affecting mainly the poorest populations. Pharmaceuticals and chemotherapies available for leishmaniasis treatment have several limitations, which clearly justify the efforts to find new potential antileishmanial drugs. In this context, antiprotozoal activities toward different species have been reported for hypervalent tellurium compounds, which motivated us to investigate, for the first time, the leishmanicidal properties of some nonhypervalent diaryl ditellurides. Thus, this work describes activity against and the cytotoxicities of diaryl ditellurides. Ditelluride revealed a strong leishmanicidal activity on promastigotes and amastigotes at submicromolar levels (IC = 0.9 ± 0.1 and 0.5 ± 0.1 μmol L, respectively) and presented selectivity indexes greater than those of reference drug miltefosine. This preliminary study suggests that diaryl ditellurides may be promising scaffolds for the development of new agents for leishmaniasis treatment.
利什曼病是一种被忽视的热带疾病,在至少98个国家引起公共卫生关注,主要影响最贫困人群。现有的用于治疗利什曼病的药物和化疗方法有若干局限性,这显然说明有必要努力寻找新的潜在抗利什曼病药物。在此背景下,已有报道称高价碲化合物对不同物种具有抗原生动物活性,这促使我们首次研究一些非高价二芳基二碲化物的杀利什曼特性。因此,这项工作描述了二芳基二碲化物的活性和细胞毒性。二碲化物在亚微摩尔水平(IC分别为0.9±0.1和0.5±0.1 μmol/L)对前鞭毛体和无鞭毛体显示出强大的杀利什曼活性,且其选择性指数高于参考药物米替福新。这项初步研究表明,二芳基二碲化物可能是开发治疗利什曼病新药物的有前景的骨架。